Cigna Group (CI) Competitors

$284.69 +2.67 (+0.95%)

As of 01:49 PM Eastern

CI vs. CNC, CVS, ELV, HCA, and HUM

Should you buy Cigna Group stock or one of its competitors? MarketBeat compares Cigna Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cigna Group include Centene (CNC), CVS Health (CVS), Elevance Health (ELV), HCA Healthcare (HCA), and Humana (HUM). These companies are all part of the "medical" sector.

How does Cigna Group compare to Centene?

Cigna Group (NYSE:CI) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, valuation, profitability, dividends and risk.

In the previous week, Cigna Group had 17 more articles in the media than Centene. MarketBeat recorded 21 mentions for Cigna Group and 4 mentions for Centene. Cigna Group's average media sentiment score of 1.43 beat Centene's score of 0.28 indicating that Cigna Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cigna Group	18 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Centene	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

87.0% of Cigna Group shares are held by institutional investors. Comparatively, 93.6% of Centene shares are held by institutional investors. 0.6% of Cigna Group shares are held by company insiders. Comparatively, 0.4% of Centene shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Cigna Group has a beta of 0.3, suggesting that its share price is 70% less volatile than the broader market. Comparatively, Centene has a beta of 1.06, suggesting that its share price is 6% more volatile than the broader market.

Cigna Group has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cigna Group	$274.90B	0.27	$5.96B	$23.59	12.07
Centene	$198.10B	0.15	-$6.67B	-$13.14	N/A

Cigna Group has a net margin of 2.26% compared to Centene's net margin of -3.25%. Cigna Group's return on equity of 19.75% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cigna Group	2.26%	19.75%	5.30%
Centene	-3.25%	5.57%	1.54%

Cigna Group currently has a consensus target price of $339.80, indicating a potential upside of 19.31%. Centene has a consensus target price of $56.94, indicating a potential downside of 2.71%. Given Cigna Group's stronger consensus rating and higher probable upside, research analysts plainly believe Cigna Group is more favorable than Centene.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cigna Group	0 Sell rating(s)	5 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.81
Centene	2 Sell rating(s)	9 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.37

Summary

Cigna Group beats Centene on 14 of the 16 factors compared between the two stocks.

How does Cigna Group compare to CVS Health?

Cigna Group (NYSE:CI) and CVS Health (NYSE:CVS) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment, valuation and dividends.

Cigna Group currently has a consensus target price of $339.80, indicating a potential upside of 19.31%. CVS Health has a consensus target price of $98.68, indicating a potential upside of 5.27%. Given Cigna Group's higher possible upside, research analysts clearly believe Cigna Group is more favorable than CVS Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cigna Group	0 Sell rating(s)	5 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.81
CVS Health	0 Sell rating(s)	4 Hold rating(s)	22 Buy rating(s)	0 Strong Buy rating(s)	2.85

Cigna Group has a beta of 0.3, indicating that its stock price is 70% less volatile than the broader market. Comparatively, CVS Health has a beta of 0.6, indicating that its stock price is 40% less volatile than the broader market.

Cigna Group has higher earnings, but lower revenue than CVS Health. Cigna Group is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cigna Group	$274.90B	0.27	$5.96B	$23.59	12.07
CVS Health	$402.07B	0.30	$1.77B	$2.27	41.30

Cigna Group has a net margin of 2.26% compared to CVS Health's net margin of 0.72%. Cigna Group's return on equity of 19.75% beat CVS Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cigna Group	2.26%	19.75%	5.30%
CVS Health	0.72%	11.88%	3.54%

In the previous week, CVS Health had 33 more articles in the media than Cigna Group. MarketBeat recorded 54 mentions for CVS Health and 21 mentions for Cigna Group. Cigna Group's average media sentiment score of 1.43 beat CVS Health's score of 0.84 indicating that Cigna Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cigna Group	18 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CVS Health	35 Very Positive mention(s)	7 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 2.8%. Cigna Group pays out 26.5% of its earnings in the form of a dividend. CVS Health pays out 117.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cigna Group has raised its dividend for 5 consecutive years and CVS Health has raised its dividend for 4 consecutive years.

87.0% of Cigna Group shares are held by institutional investors. Comparatively, 80.7% of CVS Health shares are held by institutional investors. 0.6% of Cigna Group shares are held by company insiders. Comparatively, 0.9% of CVS Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Cigna Group beats CVS Health on 11 of the 20 factors compared between the two stocks.

How does Cigna Group compare to Elevance Health?

Cigna Group (NYSE:CI) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk.

Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.7%. Cigna Group pays out 26.5% of its earnings in the form of a dividend. Elevance Health pays out 29.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has raised its dividend for 5 consecutive years and Elevance Health has raised its dividend for 14 consecutive years. Cigna Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

87.0% of Cigna Group shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.6% of Cigna Group shares are owned by insiders. Comparatively, 0.3% of Elevance Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Cigna Group presently has a consensus target price of $339.80, suggesting a potential upside of 19.31%. Elevance Health has a consensus target price of $399.32, suggesting a potential upside of 1.53%. Given Cigna Group's stronger consensus rating and higher possible upside, analysts clearly believe Cigna Group is more favorable than Elevance Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cigna Group	0 Sell rating(s)	5 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.81
Elevance Health	0 Sell rating(s)	9 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.61

Cigna Group has higher revenue and earnings than Elevance Health. Cigna Group is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cigna Group	$274.90B	0.27	$5.96B	$23.59	12.07
Elevance Health	$199.13B	0.43	$5.66B	$23.51	16.73

Cigna Group has a beta of 0.3, indicating that its share price is 70% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.66, indicating that its share price is 34% less volatile than the broader market.

Elevance Health has a net margin of 2.62% compared to Cigna Group's net margin of 2.26%. Cigna Group's return on equity of 19.75% beat Elevance Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cigna Group	2.26%	19.75%	5.30%
Elevance Health	2.62%	15.58%	5.57%

In the previous week, Cigna Group had 12 more articles in the media than Elevance Health. MarketBeat recorded 21 mentions for Cigna Group and 9 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.43 beat Cigna Group's score of 1.43 indicating that Elevance Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cigna Group	18 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Elevance Health	8 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Cigna Group beats Elevance Health on 12 of the 20 factors compared between the two stocks.

How does Cigna Group compare to HCA Healthcare?

Cigna Group (NYSE:CI) and HCA Healthcare (NYSE:HCA) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, valuation, dividends and risk.

HCA Healthcare has lower revenue, but higher earnings than Cigna Group. Cigna Group is trading at a lower price-to-earnings ratio than HCA Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cigna Group	$274.90B	0.27	$5.96B	$23.59	12.07
HCA Healthcare	$76.39B	1.14	$6.78B	$29.08	13.54

HCA Healthcare has a net margin of 8.89% compared to Cigna Group's net margin of 2.26%. Cigna Group's return on equity of 19.75% beat HCA Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cigna Group	2.26%	19.75%	5.30%
HCA Healthcare	8.89%	-295.93%	11.21%

In the previous week, Cigna Group and Cigna Group both had 21 articles in the media. Cigna Group's average media sentiment score of 1.43 beat HCA Healthcare's score of 0.72 indicating that Cigna Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cigna Group	18 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HCA Healthcare	12 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Cigna Group has a beta of 0.3, suggesting that its share price is 70% less volatile than the broader market. Comparatively, HCA Healthcare has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market.

Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. HCA Healthcare pays an annual dividend of $3.12 per share and has a dividend yield of 0.8%. Cigna Group pays out 26.5% of its earnings in the form of a dividend. HCA Healthcare pays out 10.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has raised its dividend for 5 consecutive years and HCA Healthcare has raised its dividend for 6 consecutive years.

Cigna Group currently has a consensus price target of $339.80, indicating a potential upside of 19.31%. HCA Healthcare has a consensus price target of $515.77, indicating a potential upside of 31.03%. Given HCA Healthcare's higher possible upside, analysts clearly believe HCA Healthcare is more favorable than Cigna Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cigna Group	0 Sell rating(s)	5 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.81
HCA Healthcare	1 Sell rating(s)	7 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	2.63

87.0% of Cigna Group shares are held by institutional investors. Comparatively, 62.7% of HCA Healthcare shares are held by institutional investors. 0.6% of Cigna Group shares are held by insiders. Comparatively, 1.5% of HCA Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

HCA Healthcare beats Cigna Group on 12 of the 19 factors compared between the two stocks.

How does Cigna Group compare to Humana?

Humana (NYSE:HUM) and Cigna Group (NYSE:CI) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.1%. Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. Humana pays out 37.9% of its earnings in the form of a dividend. Cigna Group pays out 26.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has raised its dividend for 5 consecutive years. Cigna Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Humana has a beta of 0.68, meaning that its stock price is 32% less volatile than the broader market. Comparatively, Cigna Group has a beta of 0.3, meaning that its stock price is 70% less volatile than the broader market.

Cigna Group has higher revenue and earnings than Humana. Cigna Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$129.66B	0.29	$1.19B	$9.35	32.94
Cigna Group	$274.90B	0.27	$5.96B	$23.59	12.07

92.4% of Humana shares are held by institutional investors. Comparatively, 87.0% of Cigna Group shares are held by institutional investors. 0.2% of Humana shares are held by company insiders. Comparatively, 0.6% of Cigna Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Cigna Group had 1 more articles in the media than Humana. MarketBeat recorded 21 mentions for Cigna Group and 20 mentions for Humana. Cigna Group's average media sentiment score of 1.43 beat Humana's score of 0.72 indicating that Cigna Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	12 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Cigna Group	18 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cigna Group has a net margin of 2.26% compared to Humana's net margin of 0.82%. Cigna Group's return on equity of 19.75% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	0.82%	10.45%	3.75%
Cigna Group	2.26%	19.75%	5.30%

Humana presently has a consensus price target of $263.35, suggesting a potential downside of 14.50%. Cigna Group has a consensus price target of $339.80, suggesting a potential upside of 19.31%. Given Cigna Group's stronger consensus rating and higher possible upside, analysts plainly believe Cigna Group is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	4 Sell rating(s)	15 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.18
Cigna Group	0 Sell rating(s)	5 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.81

Summary

Cigna Group beats Humana on 16 of the 20 factors compared between the two stocks.

Get Cigna Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CI vs. The Competition

Export

Metric	Cigna Group	MED Industry	Medical Sector	NYSE Exchange
Market Cap	$75.30B	$50.69B	$6.38B	$23.15B
Dividend Yield	2.20%	1.79%	2.79%	4.11%
P/E Ratio	12.07	22.84	20.90	30.59
Price / Sales	0.27	0.63	547.42	14.47
Price / Cash	6.91	22.82	44.13	24.79
Price / Book	1.78	2.51	10.09	4.73
Net Income	$5.96B	$1.46B	$3.55B	$1.07B
7 Day Performance	-0.16%	1.28%	4.61%	1.80%
1 Month Performance	3.58%	13.88%	1.36%	0.24%
1 Year Performance	-8.91%	-7.98%	36.73%	28.11%

Cigna Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CI Cigna Group	4.9477 of 5 stars	$284.69 +0.9%	$339.80 +19.4%	-11.1%	$75.31B	$274.90B	12.07	67,700	Positive News Analyst Downgrade
CNC Centene	2.2529 of 5 stars	$56.17 +0.4%	$53.82 -4.2%	-5.0%	$27.77B	$194.78B	N/A	61,100	Analyst Upgrade
CVS CVS Health	4.389 of 5 stars	$92.54 +2.2%	$96.12 +3.9%	+50.3%	$118.00B	$402.07B	40.74	300,000	Trending News Analyst Forecast Insider Trade
ELV Elevance Health	4.4409 of 5 stars	$377.63 -0.1%	$384.58 +1.8%	-2.7%	$81.98B	$200.42B	16.06	97,100	Positive News Analyst Forecast
HCA HCA Healthcare	4.8377 of 5 stars	$429.22 -1.4%	$517.82 +20.6%	+2.6%	$95.29B	$75.60B	14.77	320,000	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CI) was last updated on 5/22/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cigna Group (CI) Competitors

CI vs. CNC, CVS, ELV, HCA, and HUM

How does Cigna Group compare to Centene?

Summary

How does Cigna Group compare to CVS Health?

Summary

How does Cigna Group compare to Elevance Health?

Summary

How does Cigna Group compare to HCA Healthcare?

Summary

How does Cigna Group compare to Humana?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CI vs. The Competition

Cigna Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cigna Group (CI) Competitors

CI vs. CNC, CVS, ELV, HCA, and HUM

How does Cigna Group compare to Centene?

Does the media favor CI or CNC?

Do insiders and institutionals have more ownership in CI or CNC?

Which has more risk and volatility, CI or CNC?

Which has higher valuation & earnings, CI or CNC?

Is CI or CNC more profitable?

Do analysts rate CI or CNC?

Summary

How does Cigna Group compare to CVS Health?

Do analysts rate CI or CVS?

Which has more volatility & risk, CI or CVS?

Which has higher valuation & earnings, CI or CVS?

Is CI or CVS more profitable?

Does the media refer more to CI or CVS?

Is CI or CVS a better dividend stock?

Do insiders & institutionals believe in CI or CVS?

Summary

How does Cigna Group compare to Elevance Health?

Is CI or ELV a better dividend stock?

Do insiders & institutionals believe in CI or ELV?

Do analysts recommend CI or ELV?

Which has preferable earnings & valuation, CI or ELV?

Which has more risk & volatility, CI or ELV?

Is CI or ELV more profitable?

Does the media prefer CI or ELV?

Summary

How does Cigna Group compare to HCA Healthcare?

Which has preferable earnings and valuation, CI or HCA?

Is CI or HCA more profitable?

Does the media favor CI or HCA?

Which has more volatility and risk, CI or HCA?

Is CI or HCA a better dividend stock?

Do analysts recommend CI or HCA?

Do institutionals & insiders believe in CI or HCA?

Summary

How does Cigna Group compare to Humana?

Is HUM or CI a better dividend stock?

Which has more volatility and risk, HUM or CI?

Which has higher valuation and earnings, HUM or CI?

Do insiders and institutionals have more ownership in HUM or CI?

Does the media prefer HUM or CI?

Is HUM or CI more profitable?

Do analysts rate HUM or CI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CI vs. The Competition

Cigna Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools